A phase III study in healthy women to assess the bleeding profile of women with cardiovascular risk factors using a drospirenone only pill with 4 mg over nine cycles compared to desogestrel 0.075 mg
Latest Information Update: 25 Jul 2022
At a glance
- Drugs Drospirenone (Primary) ; Desogestrel
- Indications Menstruation disorders; Pregnancy
- Focus Adverse reactions
- 25 Jul 2022 New trial record
- 28 May 2022 Results presented at the 16th Congress of the European Society of Contraception and Reproductive Health